InflaRx NV (IFRX)
1.55
+0.01
(+0.65%)
USD |
NASDAQ |
Oct 21, 16:00
1.555
0.00 (0.00%)
After-Hours: 20:00
InflaRx Net Income (Annual) : -51.50M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -51.50M |
| December 31, 2024 | -49.83M |
| December 31, 2023 | -46.13M |
| December 31, 2022 | -30.99M |
| December 31, 2021 | -53.93M |
| December 31, 2020 | -38.74M |
| Date | Value |
|---|---|
| December 31, 2019 | -59.61M |
| December 31, 2018 | -35.17M |
| December 31, 2017 | -27.34M |
| December 31, 2016 | -9.888M |
| December 31, 2015 | -5.453M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -1.282B |
| Immatics NV | -221.71M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |